Pharmacists in Lake Ronkonkoma, New York


12 Pharmacists found in Lake Ronkonkoma
male pharmacist

Mr. Andrew William Caradona, RPH


Pharmacist
640 Hawkins Ave, Lake Ronkonkoma, NY 11779
631-471-1060    

female pharmacist

Farrah L Merendina, RPH


Pharmacist
449 Portion Rd, Lake Ronkonkoma, NY 11779
631-737-1736     631-737-2879

male pharmacist

Mr. Frank Dennis Montalbano, RPH


Pharmacist
751 Hawkins Ave, Lake Ronkonkoma, NY 11779
631-467-8814    



female pharmacist

Mrs. Gail Phyllis Lampert


Pharmacist
139 Ronkonkoma Ave, Lake Ronkonkoma, NY 11779
631-981-4477     631-981-5225

male pharmacist

Mr. Joseph Patrick Frank, R.PH.


Pharmacist
640 Hawkins Ave, Lake Ronkonkoma, NY 11779
631-471-1060     631-588-7541

female pharmacist

Mrs. Kundan A Patel


Pharmacist
139 Ronkonkoma Ave, Lake Ronkonkoma, NY 11779
631-981-4477    

male pharmacist

Lyle Norton Finger, RPH


Pharmacist
601 Portion Rd, Lake Ronkonkoma, NY 11779
631-981-2550    

male pharmacist

Mahir Hossain


Pharmacist
25 9th St, Lake Ronkonkoma, NY 11779
631-428-8291    

female pharmacist

Mariam Millian Meyers, PHARM.D


Pharmacist
751 Hawkins Ave, Lake Ronkonkoma, NY 11779
631-467-0888    

male pharmacist

Mr. Otto Nicholas Minerva, R.PH.


Pharmacist
407 Hawkins Avenue, Slater Pharmacy, Lake Ronkonkoma, NY 11779
631-588-1590     631-588-7315

female pharmacist

Renee Cheung, RPH


Pharmacist
449 Portion Rd, Lake Ronkonkoma, NY 11779
631-737-1736     631-737-2879

male pharmacist

Mr. Spiro Peter Monias, RPH


Pharmacist
139 Ronkonkoma Ave, Lake Ronkonkoma, NY 11779
631-981-4477     631-981-5225


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.